Literature DB >> 3059342

Plasma catecholamines as markers for sympatho-adrenal activity in human primary hypertension.

P Hjemdahl1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3059342     DOI： 10.1111/j.1600-0773.1988.tb02034.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN： 0901-9928


× No keyword cloud information.
  6 in total

1.  Platelet in vitro responses to urapidil and prazosin.

Authors:  C C Smith; D J Betteridge; B N Prichard
Journal:  Drugs       Date:  1990       Impact factor: 9.546

2.  Changes in plasma catecholamine and neuropeptide Y levels after sympathetic activation in dogs.

Authors:  M F Poncet; C Damase-Michel; G Tavernier; M A Tran; M Berlan; J L Montastruc; P Montastruc
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

3.  Interactions between domperidone and ropinirole, a novel dopamine D2-receptor agonist.

Authors:  C de Mey; D Enterling; I Meineke; S Yeulet
Journal:  Br J Clin Pharmacol       Date:  1991-10       Impact factor: 4.335

4.  Is neuropeptide Y co-released with catecholamines in experimental arterial hypertension following sinoaortic denervation?

Authors:  G Tavernier; C Damase-Michel; G Portolan; M A Tran; J L Montastruc
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

5.  Catecholamine pathway gene variation is associated with norepinephrine and epinephrine concentrations at rest and after exercise.

Authors:  Laxmi V Ghimire; Utkarsh Kohli; Chun Li; Gbenga G Sofowora; Mordechai Muszkat; Eitan A Friedman; Joseph F Solus; Alastair J J Wood; C Michael Stein; Daniel Kurnik
Journal:  Pharmacogenet Genomics       Date:  2012-04       Impact factor: 2.089

6.  Attenuation of autonomic nervous system functions in hypertensive patients at rest and during orthostatic stimulation.

Authors:  Maria Karas; Pierre Larochelle; Robert A LeBlanc; Bruno Dubé; Reginald Nadeau; Jacques de Champlain
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-02       Impact factor: 3.738
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.